Search results | clinical

Reports

Pre-clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

The Preclinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter preclinical stage licensing/business development and other forms of partnering arrangement.

Clinical Stage Partnering Terms and Agreements in Pharma and Biotech

The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the clinical stage agreements entered into by the worlds leading biopharma companies.

Sensory Organ Partnering Terms and Agreements

The Sensory Organ Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter sensory organ partnering deals.

Public Health Partnering Terms and Agreements

The Public Health Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter public health partnering deals.

Ophthalmics Partnering Terms and Agreements

The Ophthalmics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter ophthalmics/ophthalmology partnering deals.

Hospital Care Partnering Terms and Agreements

The Hospital Care artnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter hospital care partnering deals.

Genetic Disorders Partnering Terms and Agreements

The Genetic Disorders Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter genetic disorders partnering deals.

Dermatology Partnering Terms and Agreements

The Dermatology Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter dermatology partnering deals

Trends in Therapeutic Partnering

The Trends in Therapeutic Partnering report provides the most comprehensive and in-depth insight into the 35 most popular therapeutic targets for partnering in the period 2009 to mid 2014.

Co-development Terms and Agreements in Pharma, Biotech and Diagnostics

The Co-development Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies.   The report provides a detailed understand and analysis of how and why companies enter co-development deals.   Understanding the flexibility of a prospective more »

Insights

Pharma and biotech clinical stage partnering – recent trends 2009 to 2014

Partnering trends for the top pharma and biotech companies reviewed with over 2,000 deals analyzed – including summary biopharma deal financials

Preclinical stage partnering – recent trends 2009 to 2014

Recent trends in preclinical partnering for the top pharma and biotech companies reviewed, over 2,000 deals analyzed – including summary of biopharma deal financials

Galapagos – Rapidly taking identified targets through to clinical development

Galapagos is a clinical stage biotechnology company headquartered in Belgium discovering and developing candidates to phase I/II development.

Discovery, Preclinical and Clinical Stage – recent trends in pharma and biotech partnering 2009 to 2014

Discovery, preclinical and clinical stage pharma and biotech partnering forms a critical part of the drug candidate commercialization process.

Preclinical stage partnering

Preclinical stage partnering refers to a commercial deal or alliance signed when a compound or product…

Clinical stage partnering

Clinical stage partnering refers to a commercial deal or alliance signed when a compound or product is …

J&J receives bids for Ortho Clinical Diagnostics unit

Some of the world’s largest private equity firms have made preliminary offers for Johnson & Johnson’s Ortho Clinical Diagnostics unit

Dealtalk: Johnson & Johnson kicks off $5 billion clinical diagnostics unit sale

In dealtalk, Johnson & Johnson launched a sale process for its Ortho Clinical Diagnostics unit for around $5 billion.

Biotech rumor mill: J&J selling Ortho Clinical Diagnostics unit?

A biotech rumor mill reports Johnson & Johnson’s plan to sell its Ortho Clinical Diagnostics business if it can find the right price

Novartis and Walgreens to team on clinical trials

As pressures mount to boost profits and lower costs, drugmakers are, of course, looking for new ways to generate more prescriptions and improve patient adherence. So it is not surprising that Novartis would reach out to Walgreens, which is one of the largest pharmacy chains in the US, to discuss various efforts that might benefit more »

Events

Development agreement for human regenerative therapy with induced pluripotent stem cells

Catalent Pharma Solutions announced an agreement with the Center for iPS Cell Research and Application at Kyoto University in Japan to make a major advancement toward one of the first regenerative human therapies with induced pluripotent stem (iPS) cells applicable to humans.

Collaborative R&D for prostate cancer prognostic test

Definiens and Metamark Genetics announced a multi-year agreement covering use of the Definiens image analysis solution for the ProMark.

BIO Advanced Business Development Course

Attendance is limited to 75 participants to ensure the optimal instructor/student ratio and quality interaction. 

Deals

Merck and Tetralogic in solid tumor clinical pact

TetraLogic and Merck will collaborate on a Phase 1 study

Merck and Syndax partner for cancer combo clinical

Syndax and Merck have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining entinostat, an investigational epigenetic therapy, with KEYTRUDA

Pfizer and HemoShear to develop predictive model for preclinical drug-induced vascular injury

HemoShear announced a multi-year platform collaboration with Pfizer

Merck and Enumeral predicting clinical drug response

Enumeral Biomedical has signed an oncology-focused collaborative study agreement with Merck

BMS, Ono, Kyowa in nivolumab-ogamulizumab clinical evaluation

Ono Pharmaceutical, Bristol-Myers Squibb Company and Kyowa Hakko Kirin have entered into a clinical trial collaboration agreement to conduct a Phase 1 combination study

BMS and Duke form a pharma alliance for clinical trial transparency

Bristol-Myers Squibb announced a pharma alliance with Duke University through its Duke Clinical Research Institute focused on clinical trial transparency.

Carlyle Group in business merger for J&J’s ortho clinical diagnostics unit

Carlyle Group is nearing an agreement to acquire Johnson & Johnson’s ortho clinical diagnostics unit, in a deal expected to be worth around $4 billion

Collaborative R&D for application of next generation sequencing test for clinical molecular diagnostic testing

GENEWIZ and Beijing ACCB Biotech Ltd. announced a collaboration for the application of next generation sequencing tests toward the advancement of clinical molecular diagnostics.

Sellas Clinicals in pharma licensing deal for $531.4 million with Fosun Pharma

Shanghai Fosun Pharma plans to sell ex-China rights for two drug candidates in pharma licensing deal– one treating cancer, the other diabetes – to Sellas Clinicals Holding of Switzerland

Licensing agreement for early-onset morbid obesity pre-clinical program

IRICoR and Université de Montréal License a Novel Program for Early-Onset Morbid Obesity to Pfizer